NASDAQ · Healthcare · Biotechnology
Braveheart Bio, Inc.
BRVE
Braveheart Bio, Inc. CEO Travis Murdoch · Market cap $1.9B.
$27.58
+0.16 · +0.58%
52w hi $32.0052w lo $24.61
Off 52w high 21.8%
80
STRONG
Current InsiderScore
Corp · 90d
12
12 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
11
5 strong · 6 notable
Analyst consensus
—
—
Section 01
Recent Form 4 filings
12 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Aug 07 | Erez Chimovits | Buy | 1,666,667 | $18.00 | +$30.00M | 76 | |
| Aug 07 | ORBIMED ADVISORS LLC | Buy | 1,666,667 | $18.00 | +$30.00M | 76 | |
| Aug 07 | AH Bio Fund IV, L.P. | Buy | 1,100,000 | $18.00 | +$19.80M | 76 | |
| Aug 07 | Erez Chimovits | Buy | 273,333 | $18.00 | +$4.92M | 80 | |
| Aug 07 | ORBIMED ADVISORS LLC | Buy | 273,333 | $18.00 | +$4.92M | 80 | |
| Aug 07 | Travis Murdoch | CEO and President | Buy | 83,333 | $18.00 | +$1.50M | 70 |
| Aug 07 | David Charles Lubner | Buy | 55,555 | $18.00 | +$1000K | 71 | |
| Aug 07 | Forbion Growth Opportunities Fund III Cooperatief U.A. | Buy | 1,680,000 | $18.00 | +$30.24M | 74 | |
| Aug 07 | Forbion Growth Opportunities Fund III Cooperatief U.A. | Buy | 1,920,000 | $18.00 | +$34.56M | 74 | |
| Aug 07 | James Paul Rickey | Chief Financial Officer | Buy | 27,777 | $18.00 | +$500K | 64 |
| Aug 07 | David I Malek | Buy | 4,166 | $18.00 | +$75K | 52 | |
| Aug 07 | Christopher Viehbacher | Buy | 83,333 | $18.00 | +$1.50M | 67 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug